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Abstract
The present study reports the epidemiological investigations undertaken in one of Krakow’s city hospitals regarding the source of infection
and the routes of transmission of a group A streptococcus (Streptococcus pyogenes), using ﬂuorescent in situ hybridization as a rapid method
for detecting S. pyogenes carriage in the medical personnel involved. Four patients from the gynaecology department and two patients from
the surgery department presented with clinical signs of infection. Characteristics of the S. pyogenes strains isolated from patients and
from one medical staff member, including the emm gene and superantigens encoding genes, are described. All patients (four conﬁrmed
and two probable cases) survived; the operating theatre aid was identiﬁed as an S. pyogenes carrier and the source of the infections.
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Introduction
Streptococcus pyogenes, group A streptococcus (GAS), is the
cause of invasive infections such as necrotizing fasciitis and
toxic shock syndrome, which occur with increasing incidence
all over the world [1]. The US Centers for Disease Control and
Prevention (CDC) reported an average of 3.5 cases of invasive
GAS infections per 100 000 population in 2000–2004 [2]. In
hospitals, person-to-person spread of GAS infection occurs via
respiratory droplets and by direct contact. There are reports
of outbreaks of post-partum GAS infection related to the
spread of GAS from healthcare personnel to patients [3–6].
S. pyogenes strains that cause invasive GAS infections usu-
ally produce one or more special proinﬂammatory toxins
(superantigens, commonly SpeA or SpeC) [7,8]. Bacterial
superantigens lead to the faster proliferation of T-lymphocytes
and the liberation of a signiﬁcant amount of proinﬂammatory
cytokines causing toxic shock syndrome [9].
Standard methods of molecular typing are now widely used
to monitor the epidemiology of invasive GAS infections
[2,10,11]. These methods are based on a comparison of emm
gene sequences coding for M protein and the detection of su-
perantigens. In addition, multilocus sequence typing is used
[12,13]. These procedures are standardized to allow compari-
son of invasive S. pyogenes infections all over the world and
to aid in the selection of preventive measures [11,14,15].
In October 2007, there was an outbreak of invasive GAS
infections in a city hospital in Krakow with clinical signs and
symptoms resembling necrotizing fasciitis. The present study
aimed to analyse the characteristics of the S. pyogenes strains
involved in the outbreak, including the emm gene as well as
genes coding for superantigens. In addition, pulse ﬁeld gel
electrophoresis (PFGE) was used to determine the genetic
relatedness among the isolates.
The study also investigated the source of infection and the
probable routes of transmission of the outbreak strain, using
ﬂuorescent in situ hybridization (FISH) as a rapid method for
detecting S. pyogenes carriage.
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Materials and Methods
Patients and healthcare workers
Four patients from the gynaecology department and
two patients from the general surgery department with symp-
toms of suspected invasive GAS infection were investigated.
They were hospitalized during 16–23 October 2007, in the
Hospital of the Ministry of Internal Affairs and Administration,
Krakow. Invasive GAS infection was deﬁned as the presence of
streptococcal toxic shock syndrome symptoms or necrotizing
fasciitis with simultaneous isolation of S. pyogenes from nor-
mally sterile sites such as blood, or from a nonsterile site such
as the vagina [15–17]. The criteria for diagnosing surgical site
infection were based on the recommendations of the National
Nosocomial Infection Surveillance System, CDC [18].
After the initial isolation of S. pyogenes from patients, an
epidemiological investigation was carried out to detect the
source of this streptococcus in patients and the medical per-
sonnel on the ward at the time. The investigations were per-
formed by the local infection control team supported by the
medical and microbiological staff.
Samples from patients and staff
Surgical site, perianal, vaginal and throat swabs and urine
were collected from women who had undergone Caesarian
sections. Blood was collected from women who presented
with signs of systemic infection. Neonates had nasal and
pharyngeal cultures. General surgery department patients
had swabs collected from the surgical site, nose and throat.
Nasal and pharyngeal samples were collected from the
medical staff and, in the case of female staff, perianal and
vaginal swabs were taken.
Microbiological tests
After collection, the samples were placed in transport media
and delivered to the Chair of Microbiology in Krakow, where
they were cultured on Columbia Agar (Difco, Franklin Lakes,
NJ, USA) with 5% sheep blood, McConkey Agar (Oxoid, Basing-
stoke, UK), Columbia Agar (Difco) with 5% sheep blood and
vitamin K and Sabouraud Agar (bioMe´rieux, l’Etoile, France).
Blood samples were placed into Plus Anaerobic/F liquid medium
(Becton-Dickinson Biosciences, Franklin Lakes, NJ, USA) and
incubated in a BACTEC 9050 blood culture system for 10 days.
Streptococcus species identiﬁcation. The API20 Strep test (bio-
Me´rieux) and a serological grouping latex agglutination test
(Oxoid) were used for identiﬁcation. S. pyogenes species
identiﬁcation was conﬁrmed with a PCR based on the
speciﬁc S. pyogenes primers: spy 1258F (5¢-AAA GAC CGC
CTT AAC CAC CT-3¢) and spy 1258R (5¢-TGG CAA GGT
AAA CTT CTA AAG CA-3¢), designed for a transcriptional
regulator gene (spy1258). The ampliﬁcation product had a
size of 407 bp [19].
All isolated S. pyogenes strains were additionally tested for
the MLSB-type resistance by the disc-diffusion method with
Mueller–Hinton solid medium containing 5% sheep blood
together with erythromycin (15 lg) and clindamycin (2 lg)
discs [20].
PFGE. PFGE was performed according to Yano et al. [21] to
type 16 GAS strains. Restriction enzyme digestion was per-
formed with 25 U of SmaI enzyme in Tango buffer (Fermentas,
Glen Burnie, MD, USA). The blocks were placed into 1% aga-
rose gel, and the electrophoresis was conducted in a CHEFIII
PFGE unit applying the parameters: starting pulse 1 s, ending
pulse 50 s, voltage 6 V/cm, time of partition 24 h. The image
was visualized with the QuantityOne (Bio-Rad, Hercules, CA,
USA) programme; the gel analysis and dendrogram were per-
formed with the MolecularAnalyst programme (Bio-Rad).
PCR methods. The presence of the emm gene was shown by
the PCR method of Podbielski et al. [22], with ‘all M prim-
ers’: all M for (5¢-ATA AGG AGC ATA AAA ATG GCT-3¢),
all M rev (5¢-AGC TTA GTT TTC TTC TTT GCG-3¢).
PCR ampliﬁcation products were sequenced using an ABI
Prism310 Genetic Analyzer (Applied Biosystems, Darms-
tadt, Germany). The sequences were compared with all
sequence patterns available on the CDC web site (http://
www.cdc.gov/ncidod/biotech/strep/strepblast.htm). The emm
gene type was indicated when the degree of identity
between the sequences was higher than 95%. The presence
of genes coding the superantigens SpeA, SpeC and Ssa was
determined as described by Brandt et al. [23].
FISH. To allow for fast detection of S. pyogenes carriage during
the epidemiological investigation, FISH was used with a probe
complementary to the 16S rRNA sequence of S. pyogenes
(Strpyo: CTA-ACA-TGC-GTT-AGT-CTC-TC) marked at the
5¢ end with the ﬂuorescent dye CY3 [24]. The rest of the bac-
terial DNA was stained with the ‘universal’ bacterial probe
‘EUB338’ (GCT-GCC-TCC-CGT-AGG-AGT) marked at the
5¢ end with ﬂuorescein. The samples were transferred onto
sterile Super Frost Plus slides (Menzel-Gla¨ser, Braunschweig,
Germany). Fixation and hybridization were carried out accord-
ing to Hogardt et al. [24] and Artz et al. [25] followed by
examination with a ﬂuorescence microscope: S. pyogenes
appeared orange–red and the remaining bacteria were green.
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Results
Four patients from the gynaecology department presented
with clinical signs of infection within 24 h of Caesarian
section. Symptoms varied among the patients, including fever
>38C, tachycardia, vulvar oedema, surgical site tenderness,
abdominal pain with some signs of ileus and oedema along
the upper legs and progressive purpura, leading to extension
of the surgical site necrosis.
Two patients from the general surgery department were
also affected: one of them after a hernia repair and the other
after vascular surgery of lower leg varices. Signs and symp-
toms appeared on the second and third day post-surgery
and were not fulminant. Both patients presented with ulcer-
ations of the incision site, cellulitis, headaches, general weak-
ness and fever >38C.
There were ten Caesarian sections and 38 other surgical
procedures performed in the same operating room during
the same time period. Caesarian sections were both elective
as well as emergency; none of the patients’ amniotic ﬂuids
tested positive for inﬂammatory markers; therefore, their
operating ﬁelds were classiﬁed as ‘clean-contaminated’.
None of the six patients received perioperative antibiotic
prophylaxis. For the S. pyogenes infection, the female patients
were treated with a combination of penicillin and clindamycin,
whereas the surgical patients were treated with high doses of
penicillin only. All patients survived.
As soon as the infections were detected, it was decided
to stop all surgical procedures until the source of infection
was found and eliminated. The epidemiological investigation
was centred on the possibility of transmission from a
carrier among the health personnel: the high risk group
comprised the 26 medical personnel present during the
procedures that resulted in infection. S. pyogenes was
isolated from one of the operating theatre aids who was
present during all six procedures that ended up with
S. pyogenes infection.
Table 1 shows the screening results. A total of 19 b-hae-
molytic ‘streptococci’ were isolated, of which 14 were classi-
TABLE 1. Isolation of Streptococcus pyogenes from different samples during the hospital outbreak
Patient/personnel Department/procedure type
Sample collection site or type
Surgical site Throat Urine Vagina Anus Blood
Patient 1 Gynaecology/Caesarean section + ) + + + )
Patient 2 Gynaecology/Caesarean section + ) + + + )
Patient 3 Gynaecology/Caesarean section ) ) ) ) ) )
Patient 4 Gynaecology/Caesarean section ) ) ) ) ) )
Patient 5 Surgery/hernia + ) ) Not tested + )
Patient 6 Surgery/varicose veins of lower leg + ) ) ) ) )
Personnel: operation
theatre aid
Operating block Not applicable + ) +a(test performed
twice resulting in
2 S. pyogenes isolates)
)a Not tested
+S. pyogenes was conﬁrmed by culture methods.
)S. pyogenes was not conﬁrmed by culture methods.
aStreptococcus agalactiae was additionally isolated.
FIG. 1. PCR with species-speciﬁc primers for Streptococcus pyogenes: spy 1258F and spy1258R. Fourteen GAS strains were successfully speciated
(PCR ampliﬁcation product of 407 bp). Strains 15–19 belonged to other streptococcal species. M, Size markers.
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ﬁed as S. pyogenes, as conﬁrmed by both conventional and
genetic methods (Fig. 1). S. pyogenes was not isolated by
screening from the two of the four affected patients from
the obstetrics and gynaecology department, probably as a
result of the prompt introduction of empirical antibiotic
therapy directed against S. pyogenes.
No MLSB-type resistance was demonstrated in any of the
14 S. pyogenes isolates using the disc-diffusion method. PFGE
showed a high degree of genetic relatedness (>90%) among
the 14 isolates, indicating that they came from the same bac-
terial clone (Fig. 2). This was conﬁrmed by the results of
emm gene detection, which showed that all 14 isolates had
the same type 28 emm gene, and the presence of an identical
pattern of genes coding for superantigens (i.e. the presence
of speC gene and lack of ssa and speA) (Table 2).
In addition to the traditional culture methods, we also
used FISH with Strpyo and EUB338 probes [24]. With this
method, and after just 4 h from sample collection, S. pyoge-
nes was detected both in the pharyngeal and vaginal samples
of the S. pyogenes carrier. This was conﬁrmed by conven-
tional methods 24 h after sample collection. Furthermore,
using FISH on vaginal samples from the staff carrier, it was
found that she was colonized with another streptococcus,
identiﬁed as a group B b-haemolytic streptococcus (Strepto-
coccus agalactiae). (Fig. 3),
As a consequence of these infections, all physicians
received appropriate training and routine perioperative anti-
microbial prophylaxis was implemented into practice accord-
ing to current guidelines [26]. The S. pyogenes carrier was
removed from work at the theatre, treated with systemic
b-lactam antibiotics, and checked for eradication of the
streptococcus by three consecutive throat swab cultures.
Discussion
Our collaboration during this outbreak resulted in the suc-
cessful treatment of all patients with invasive GAS infection,
including the four post-Caesarian section infections, and in


















FIG. 2. Pulse ﬁeld gel electrophoresis pattern analysis of Streptococ-
cus pyogenes isolates. GAS strains 1–12 were isolated from patients
in the gynaecology and surgery departments, GAS strains 13 and 14
were isolated from the throat and vagina of an asymptomatic carrier.
GAS strains 15 and 16 originated from an internal collection of the
Chair of Microbiology Jagiellonian University Medical College and
show a different restriction pattern [(Molecular Analyst, Bio-Rad)
(16 entries) Jaccard coeff. (tolerance 6.0%, optimization, 0.50%,
minimum area 0.0%) (unweighted pair group method with arithmetic
mean)].
TABLE 2. Molecular characteristics of Streptococcus pyoge-
nes isolates from hospital outbreak
Strain number SpeA SpeC Ssa All M-PCR emm-type
1 ) + ) + 28
2 ) + ) + 28
3 ) + ) + 28
4 ) + ) + 28
5 ) + ) + 28
6 ) + ) + 28
7 ) + ) + 28
8 ) + ) + 28
9 ) + ) + 28
10 ) + ) + 28
11 ) + ) + 28
12 ) + ) + 28
13 ) + ) + 28
14 ) + ) + 28
FIG. 3. Fluorescent in situ hybridization used for direct detection of
Streptococcus pyogenes in the material collected from the vagina of
the nurse from the operating block accessory personnel. S. pyogenes
appears orange as a result of staining with the Strpyo probe; other
bacteria (mainly Streptococcus agalactiae) look green with the EUB338
probe [24] (Olympus BX51 ﬂuorescence microscope, · 1000 ;
Olympus, Tokyo, Japan).
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theatre staff. Moreover, it was possible to type the S. pyoge-
nes outbreak strain and to conﬁrm its high virulence poten-
tial by molecular methods.
Invasive streptococcal infections present a global problem
that has to be solved by epidemiologists and microbiologists
working together [14]. CDC and the ‘Strep-EURO’ initiative
are attempting to ﬁnd out why there is such high virulence
among recently isolated group A streptococci: is it a result
of lowered host immunity or the ocurrence of new strep-
tococcal virulence factors? [8,27,28]. It has been demon-
strated that invasive S. pyogenes strains have a special toxic
potential as a result of the production of superantigens
(Spe). Certain spe gene proﬁles predominate in invasive
S. pyogenes isolates depending on their emm type; the pres-
ence of a speciﬁc gene coding for the corresponding super-
antigen does not depend on the geographical area where
the infection occurred [29]. Some studies emphasize that
GAS causing the most severe invasive disease possess SpeC
[30] or Spe A [31].
Outbreaks of post-partum GAS infection have been
reported repeatedly over the last 25 years. Most have been
related to the spread of GAS among post-partum patients by
healthcare workers who are asymptomatic carriers [4–6]. This
epidemiological picture was also seen in the outbreak reported
in the present study. The clinical picture of our four post-
Caesarian section patients was also typical, although more
signs of local tissue necrosis were observed. Women with
post-partum GAS sepsis generally present within the ﬁrst
24 h after delivery with fever, hypotension, tachycardia,
leukocytosis, haemolysis and disseminated intravascular
coagulation [32].
The SpeC toxin gene was detected in all strains isolated
from the four patients in the two departments affected, which
supports the assumption of a common origin of the strains
and also explains the rapid course of these infections, espe-
cially among women after Caesarian section. Moreover, analy-
sing the emm type gene coding for the M protein, the same
type (emm28) was shown in all 14 S. pyogenes isolates. On the
basis of epidemiological data collected by Luca-Harari et al.
[10], emm type 28 was the one most often isolated in the
years 2003–2004 from invasive GAS infections in Denmark.
Other studies have shown an increase in numbers of emm28
GAS, from 15% in 1999 to 26% in 2004 in this country [33];
and increasing numbers of emm28 in Finland from 1995 to
2004 [34] and also over several years in other European coun-
tries [8,11]. Seasonal ﬂuctuation in emm28 frequency over
time has also been demonstrated [8]. Interestingly, it is also
known that emm28 GAS have an additional surface protein
R28, which is closely related to the Rib protein present on
group B streptococci, showing very strong adherence to vagi-
nal epithelial cells [35]. In the present study, the source of
infection was the operating theatre aid who carried the same
streptococcus strain as the infected patients not only in the
pharynx, but also in the vagina, which is consistent with the
hypothesis of a special afﬁnity of emm28 GAS to the female
genital tract; see also recent epidemiological data from Europe
[8]. In the present study, we did not use MLST typing,
although this method may be used in the future to compare
our GAS strain with those reported recently in other Euro-
pean countries such as Sweden [36].
In Poland, several cases of invasive group A streptococcal
infections were described in 1996–2002 occurring in centres
throughout the country [16]. The present study describes an
outbreak in southern Poland with the ﬁrst use of FISH
S. pyogenes speciﬁc probes for the epidemiological investiga-
tion. This method allowed the detection of the asymptom-
atic carrier of this streptococcus within hours of sample
collection and enabled the authorities to immediately
remove that person from professional duties. Although FISH
methods are rather expensive, their use may be justiﬁed if
the source of a serious hospital infection has to be identiﬁed
urgently.
Because of the high mortality and rapid course of invasive
S. pyogenes infections, additional training of hospital person-
nel is needed to introduce appropriate procedures for the
prevention of infections (e.g. antibiotic prophylaxis) and to
enable special measures for collecting and securing samples
for microbiological analyses. Because hospital-acquired GAS
infections are being reported continuously world-wide
[8,37], guidance on the management of invasive GAS out-
breaks should be reviewed at both national and European
levels. Such guidance documents would be very useful for
infection control teams, infectious disease specialists and clin-
ical microbiologists across Europe. The present study,
together with other recent reports [10,11,38], may serve as
good basis for such an initiative.
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